The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-methoxyphenyl)-N-(2-(4-sulfamoylphenylamino)-5,6-dihydrobenzo[h]quinazolin-8-yl)acetamide ID: ALA1084088
PubChem CID: 46890256
Max Phase: Preclinical
Molecular Formula: C27H25N5O4S
Molecular Weight: 515.60
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(CC(=O)Nc2ccc3c(c2)CCc2cnc(Nc4ccc(S(N)(=O)=O)cc4)nc2-3)cc1
Standard InChI: InChI=1S/C27H25N5O4S/c1-36-22-9-2-17(3-10-22)14-25(33)30-21-8-13-24-18(15-21)4-5-19-16-29-27(32-26(19)24)31-20-6-11-23(12-7-20)37(28,34)35/h2-3,6-13,15-16H,4-5,14H2,1H3,(H,30,33)(H2,28,34,35)(H,29,31,32)
Standard InChI Key: IVFKBDVWDXZDKD-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
22.1708 1.5458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.5875 0.8292 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.9998 1.5483 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3081 -0.8319 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0245 -0.4185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0216 0.4120 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3063 0.8211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4516 -0.8277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4505 -1.6536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1697 -2.0665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8811 -1.6528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7396 -0.8299 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4534 -0.4163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1652 -0.8281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8785 -0.4152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8777 0.4107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1575 0.8219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4472 0.4066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3066 0.4149 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1659 -0.4164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8817 -0.8335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5969 -0.4245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6025 0.4034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8867 0.8205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1653 0.4097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7363 -2.0664 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0216 -1.6543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0211 -0.8293 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3073 -2.0672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5926 -1.6551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5959 -0.8299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8821 -0.4179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1669 -0.8308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1700 -1.6601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8844 -2.0684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4548 -0.4216 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7411 -0.8355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17 18 2 0
18 13 1 0
16 2 1 0
8 9 2 0
2 19 1 0
20 21 2 0
4 5 2 0
9 10 1 0
3 2 2 0
10 11 2 0
11 21 1 0
5 6 1 0
20 25 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 1 0
5 12 1 0
9 26 1 0
26 27 1 0
12 13 1 0
27 28 2 0
6 7 2 0
27 29 1 0
13 14 2 0
29 30 1 0
7 23 1 0
30 31 2 0
14 15 1 0
31 32 1 0
22 4 1 0
32 33 2 0
15 16 2 0
33 34 1 0
20 8 1 0
34 35 2 0
35 30 1 0
16 17 1 0
2 1 2 0
36 37 1 0
33 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 515.60Molecular Weight (Monoisotopic): 515.1627AlogP: 3.82#Rotatable Bonds: 7Polar Surface Area: 136.30Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.69CX Basic pKa: 1.65CX LogP: 4.29CX LogD: 4.28Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.34Np Likeness Score: -1.35
References 1. Crombie AL, Sum FW, Powell DW, Hopper DW, Torres N, Berger DM, Zhang Y, Gavriil M, Sadler TM, Arndt K.. (2010) Synthesis and biological evaluation of tricyclic anilinopyrimidines as IKKbeta inhibitors., 20 (12): [PMID:20471256 ] [10.1016/j.bmcl.2010.04.022 ]